ASH 2019: Sutimlimab Offers Hope of First Effective Treatment for Cold Agglutinin Disease
Targeting C1s complement pathway appears to be therapeutic for this condition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.